![](https://investorshub.advfn.com/uicon/492638.png?cb=1552145011)
Tuesday, November 28, 2017 4:14:48 PM
The one shot at a success has turned out to be the FDA announcement--for about a month (FEB-MAR 2017) which is how long it took researchers to realize that the "FDA Approval" wasn't anything at all.
The Actipatch (AKA GIZMO) is worthless. Repeat sales are nill, and one time first buyers are gone.
It never reached critical mass for three reasons
* One it doesn't work
* Two no one wanted to promote it
* Three see #1 and #2
So the exit came and went.
And now all that's left is 2,000,000,000 shares being dumped in dilution( heading towards that 20 BILLION OUTSTANDING MILESTONE)---and ultimately the company folding--and becoming the 100% property of IBEX LLC--which is 100% OWNED by Kelly, surely for her dad, BIELS CEO.
Not hard to figure out.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM